Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biotechnology firm ContraVac has said that the FDA has approved SpermCheck Vasectomy, a simple diagnostic which confirms men's post-vasectomy sterility.
Subscribe to our email newsletter
The device will enable men to test their post-vasectomy fertility status at home rather than requiring the patient to return to the physician’s office or a laboratory. Physicians will be able to provide SpermCheck Vasectomy to their patients following their vasectomy or men can purchase SpermCheck Vasectomy directly from ContraVac. SpermCheck Vasectomy will be commercially available in the US by summer 2008.
Ed Leary, president of ContraVac said: “The convenience and privacy SpermCheck Vasectomy provides is anticipated to improve the compliance rate for post-vasectomy sperm testing, resulting in fewer unwanted pregnancies and providing greater peace of mind.”